Molecular Approach, Pinpoint Accuracy
Infectious diseases can be difficult to diagnose accurately – or at all. Similar signs and indications, along with imprecise symptoms present a real challenge when relying on traditional lab tests. Their results can lead to ineffective initial treatments and poor outcomes.
Thanks to new molecular pathology testing, Cabot Lab delivers a depth of information that was never before available, including:
- More precise results
- Identification across a broad spectrum of pathogens
- Genetic footprint of pathogens and increased identification of co-infections
- Antibiotic Resistance
UTI
With Cabot Lab’s advanced UTI panel, a single urine specimen yields deep and broad results that are superior to traditional testing methods – without culture.
- Simultaneously pinpoints 24 bacterial and fungal pathogens
- Can provide polymicrobial findings
- Approximately 30% more sensitivity than a culture
- Identifies organisms that traditional methods often miss
- Turnaround time of 24 hours
GPP
Our Gastrointestinal Pathogen panel frees you from managing multiple stool samples and a variety of testing methods to diagnose individuals with symptoms of infectious colitis or gastroenteritis.
- Identifies and detects 15 bacterial, viral and parasitic pathogen targets
- 99.9% overall negative predictive value to rule out causes of diarrhea
- Detects and identifies over 95% of causative bacterial, viral, and parasitic agents of gastroenteritis
- Turnaround time of 24 hours
RPP
Count on Cabot Lab for broader, more streamlined testing for multiple viral and bacterial agents of the upper respiratory tract—all with a single nasopharyngeal swab.
- Comprehensive panel of 22 targets
- Easy-to-use closed-tube system minimizes contamination risks
- Minimal Hands-On time
- 24-hour turn-around time
Viral Targets
- Influenza A
- Influenza A H1
- Influenza A H3
- Influenza B
- Respiratory Syncytial Virus A
- Respiratory Syncytial Virus B
- Parainfluenza 1
- Parainfluenza 2
- Parainfluenza 3
- Parainfluenza 4
- Coronavirus 229C
- Coronavirus NL63
- Coronavirus OC43
- Coronavirus HKU1
- Metapneumovirus
- Rhinovirus/Enterovirus
- Adenovirus
- Bocavirus
Bacterial Targets
- Mycoplasma Pneumoniae
- Bordetella Pertussis
- Bordetella Parapertussis
Breadth and Depth of Testing
We offer molecular pathology tests across a wide range of categories, including respiratory, gastrointestinal, wound, UTI, Genito STD and hair, nail/paronchia infectious diseases.
CGX
Healthcare professionals gain results based on a panel of 94 genes suspected to play a role in predisposing patients to cancer, including genes associated with a range of cancers.
- Breast
- Ovarian
- Prostate
- Colorectal
- Pancreatic
PGX
Cabot Lab can detect the variations in patients’ DNA that may point to an increased risk of adverse reactions to a wide range of prescription drugs. PGX testing is particularly applicable to patients with:
- Prescriptions for one or more of the 100+ FDA-approved drugs with pharmacogenetic information on the label, such as Celexa, Coumadin, Plavix, Straterra, Abilify, Lopressor/Toprol and others
- History of medication failure
- Lack of symptom relief from prescribed medication
- Previous adverse drug reaction sensitivity
- Prescription for a controlled substance
Toxicology
Concerned healthcare professionals can count on Cabot Lab for precise, prompt toxicology screening results from urine samples
- amphetamines
- barbiturates
- benzodiazepines
- methadone
- cocaine
- opiates, including codeine, oxycodone
- PCP
- THC
- alcohol, including ethanol and methanol